Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Neurofibrosarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1

Interventions

Doxorubicin 5Ifosfamide 4Filgrastim 3belinostat 2Radiotherapy 2Nivolumab 2Ipilimumab 2Imatinib Mesylate 2spartalizumab 1perifosine 1brostallicin 1balstilimab 1Vincristine 1Trabectedin 1Temozolomide 1Sunitinib 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Mass Spectrometry 1Magnetic Resonance Spectroscopy 1Injections 1Fluorouracil 1Etoposide 1Epirubicin 1Dactinomycin 1Cyproheptadine 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiosarcoma × perifosine × Gynecologic × Clear all
NCT00053794 2023-08-04

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Canadian Cancer Trials Group

Phase 2 Completed
17 enrolled
GynecologicSarcoma

Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡